Skip to main content
Download PDF

Prevalence of moderate-to-severe TR suitable for percutaneous intervention in TTE patients

Echo Research & Practice volume 5, pages 149–153 (2018)Cite this article

Abstract

Moderate-to-severe tricuspid regurgitation is associated with higher mortality and morbidity yet remains significantly undertreated. The reasons for this are complex but include a higher operative mortality for patients undergoing isolated tricuspid valve surgery. This study sought to determine the prevalence of patients with moderate-tosevere tricuspid regurgitation and identify those who could be potentially suitable for percutaneous tricuspid valve intervention by screening patients referred for transthoracic echocardiography (ECHO) at a tertiary center. Our results showed that the prevalence of moderate-to-severe tricuspid regurgitation in our total ECHO patient population was 2.8%. Of these, approximately one in eight patients with moderate-to-severe tricuspid regurgitation would be potentially suitable for percutaneous intervention and suggests a large, unmet clinical need in this population.

References

  1. Antunes MJ & Barlow JB. Management of tricuspid valve regurgitation. Heart 2007 93 271–276. (https://doiorg.publicaciones.saludcastillayleon.es/10.1136/hrt.2006.095281)

    Article  Google Scholar 

  2. Nath J, Foster E & Heidenreich PA. Impact of tricuspid regurgitation on long-term survival. Journal of the American College of Cardiology 2004 43 405–409. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2003.09.036)

    Article  Google Scholar 

  3. Topilsky Y, Nkomo VT, Vatury O, Michelena HI, Letourneau T, Suri RM, Pislaru S, Park S, Mahoney DW & Biner S. Clinical outcome of isolated tricuspid regurgitation. JACC: Cardiovascular Imaging 2014 7 1185–1194. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jcmg.2014.07.018)

    PubMed  Google Scholar 

  4. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O’Gara PT, Ruiz CE, Skubas NJ & Sorajja P. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 2014 63 2438–2488. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2014.02.537)

    Article  Google Scholar 

  5. Falk V, Baumgartner H, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR. 2017 ESC/EACTS guidelines for the management of valvular heart disease. European Journal of Cardio-Thoracic Surgery 2017 52 616–664. (https://doiorg.publicaciones.saludcastillayleon.es/10.1093/ejcts/ezx324)

    Article  Google Scholar 

  6. Kim YJ, Kwon DA, Kim HK, Park JS, Hahn S, Kim KH, Kim KB, Sohn DW, Ahn H, Oh BH, et al. Determinants of surgical outcome in patients with isolated tricuspid regurgitation. Circulation 2009 120 1672–1678. (https://doiorg.publicaciones.saludcastillayleon.es/10.1161/CIRCULATIONAHA.109.849448)

    Article  Google Scholar 

  7. Vassileva CM, Shabosky J, Boley T, Markwell S & Hazelrigg S. Tricuspid valve surgery: the past 10 years from the Nationwide Inpatient Sample (NIS) database. Journal of Thoracic and Cardiovascular Surgery 2012 143 1043–1049. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtcvs.2011.07.004)

    Article  Google Scholar 

  8. Rodés-Cabau J, Hahn RT, Latib A, Laule M, Lauten A, Maisano F, Schofer J, Campelo-Parada F, Puri R & Vahanian A. Transcatheter therapies for treating tricuspid regurgitation. Journal of the American College of Cardiology 2016 67 1829–1845. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2016.01.063)

    Article  Google Scholar 

  9. Nickenig G, Kowalski M, Hausleiter J, Braun D, Schofer J, Yzeiraj E, Rudolph V, Friedrichs K, Maisano F, Taramasso M, et al. Transcatheter treatment of severe tricuspid regurgitation with the edge-to-edge mitraclip technique Circulation 2017 135 1802–1814. (https://doiorg.publicaciones.saludcastillayleon.es/10.1161/CIRCULATIONAHA.116.024848)

    Article  Google Scholar 

  10. Hahn RT, Meduri CU, Davidson CJ, Lim S, Nazif TM, Ricciardi MJ, Rajagopal V, Ailawadi G, Vannan MA & Thomas JD. Early feasibility study of a transcatheter tricuspid valve annuloplasty: SCOUT trial 30-day results. Journal of the American College of Cardiology 2017 69 1795–1806. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2017.01.054)

    Article  Google Scholar 

  11. Taramasso M, Pozzoli A, Guidotti A, Nietlispach F, Inderbitzin DT, Benussi S, Alfieri O & Maisano F. Percutaneous tricuspid valve therapies: the new frontier. European Heart Journal 38 2017 639–647. (https://doiorg.publicaciones.saludcastillayleon.es/10.1093/eurheartj/ehv766)

    Article  Google Scholar 

  12. Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA, Badano L, Zamorano JL & Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. European Heart Journal: Cardiovascular Imaging 2013 14 611–644. (https://doiorg.publicaciones.saludcastillayleon.es/10.1093/ehjci/jet105)

    PubMed  Google Scholar 

  13. Zoghbi WA, Enriquez-Sarano M, Foster E, Grayburn PA, Kraft CD, Levine RA, Nihoyannopoulos P, Otto CM, Quinones MA, Rakowski H, et al. American Society of Echocardiography Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. Journal of the American Society of Echocardiography 2003 16 777–802. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0894-7317(03)00335-3)

    Article  Google Scholar 

  14. Stuge O & Liddicoat J. Emerging opportunities for cardiac surgeons within structural heart disease. Journal of Thoracic and Cardiovascular Surgery 2006 132 1258–1261. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jtcvs.2006.08.049)

    Article  Google Scholar 

  15. Campelo-Parada F, Perlman G, Philippon F, Ye J, Thompson C, Bédard E, Abdul-Jawad Altisent O, Del Trigo M, Leipsic J, Blanke P, et al. First-in-man experience of a novel transcatheter repair system for treating severe tricuspid regurgitation. Journal of the American College of Cardiology 2015 66 2475–2483. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2015.09.068)

    Article  Google Scholar 

  16. Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A & Hahn RT. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. Journal of the American College of Cardiology 2015 65 1190–1195. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2015.01.025)

    Article  Google Scholar 

  17. Latib A, Agricola E, Pozzoli A, Denti P, Taramasso M, Spagnolo P, Juliard JM, Brochet E, Ou P, Enriquez-Sarano M, et al. First-in-man implantation of a tricuspid annular remodeling device for functional tricuspid regurgitation. JACC: Cardiovascular Interventions 2015 8 e211–e214. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2015.08.534)

    PubMed  Google Scholar 

  18. Laule M, Stangl V, Sanad W, Lembcke A, Baumann G & Stangl K. Percutaneous transfemoral management of severe secondary tricuspid regurgitation with Edwards Sapien XT bioprosthesis: first-in-man experience. Journal of the American College of Cardiology 2013 61 1929–1931. (https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.jacc.2013.01.070)

    Article  Google Scholar 

Download references

Funding

This research did not receive any specific grant from any funding agency in the public, commercial or not-for-profit sector.

Author information

Authors and Affiliations

  1. Department of Cardiology, King’s College Hospital, London, UK

    Z. H. Teoh, J. Roy, J. Reiken, M. Papitsas, J. Byrne & M. J. Monaghan

Authors
  1. Z. H. Teoh
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. J. Roy
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. J. Reiken
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. M. Papitsas
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. J. Byrne
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. M. J. Monaghan
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Z. H. Teoh.

Rights and permissions

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.(http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Teoh, Z.H., Roy, J., Reiken, J. et al. Prevalence of moderate-to-severe TR suitable for percutaneous intervention in TTE patients. Echo Res Pract 5, 149–153 (2018). https://doiorg.publicaciones.saludcastillayleon.es/10.1530/ERP-18-0018

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1530/ERP-18-0018

Key Words

Echo Research & Practice

ISSN: 2055-0464

Contact us